
A precursor to NAD+
NMN is one of the building blocks used by the body to synthesize NAD+.

NMN, which is involved in the synthesis of NAD+, is manufactured domestically.
freeze-driedas a product.
PureStem NMN is a freeze-dried product containing 300 mg of β-nicotinamide mononucleotide (NMN) per unit.
We verify the purity and quality standards of our raw materials and provide product information and handling guidelines specifically for medical institutions.

NMN serves as a building block for the synthesis of NAD+ within the body—a molecule essential for cellular energy metabolism.
NMN (nicotinamide mononucleotide) is a substance naturally present in our bodies and acts as a precursor used to produce NAD+.
NAD+ is involved in various cellular functions, including the process by which cells generate energy from nutrients and the activity of enzymes responsible for DNA repair.
As a substance involved in NAD+ metabolism, NMN is currently the subject of research regarding its relationship to aging and health.

NMN is one of the building blocks used by the body to synthesize NAD+.

It is involved in cellular energy metabolism via NAD+.

Research is being conducted on the relationship between changes in NAD+ metabolism and aging.
Features raw materials with a purity of 99.0% or higher, and is freeze-dried and manufactured domestically.
PureStem NMN is a freeze-dried product containing 300 mg of β-nicotinamide mononucleotide per unit.
Manufactured domestically using raw materials with a purity of 99.0% or higher.
Information regarding product specifications, quality standards, and storage conditions is available for medical institutions.
Contains 300 mg of NMN per unit.
Clearly defined purity standards for raw materials.
Processed via freeze-drying (lyophilization).
Comprehensive product information—from raw material standards to storage conditions.
| Item | Specifications |
|---|---|
| Product name | PureStem NMN |
| Net Content | 300 mg per unit |
| Ingredients | β-nicotinamide mononucleotide |
| Appearance | White to pale yellow powder |
| Product form | Freeze-dried (recrystallized) product |
| Country of manufacture | Japan |
| Storage conditions | Store in a cool, dark place, away from direct sunlight |
| Handling after opening | Avoid moisture absorption; use promptly. |
| Expiration date | 2 years from the date of manufacture |
| Test Item | Specification Limit |
|---|---|
| NMN purity | ≥ 99.0% |
| Arsenic | ≤ 0.1 ppm |
| Lead | ≤ 0.05 ppm |
| Cadmium | ≤ 0.01 ppm |
| Heavy Metals | ≤ 0.5 ppm |
| Total Aerobic Microbial Count | Not detected |
| Coliform Bacteria | Negative |
| Staphylococcus aureus | Negative |
The above represents raw material quality specifications and does not indicate the actual measured values for specific lots of the finished product.
Human clinical studies on NMN safety, NAD+ metabolism, and physical function serve as scientific background information.
NMN is a precursor used in the body for the synthesis of NAD+.
In recent years, clinical studies on the oral intake of NMN have been conducted, involving healthy adults and older individuals.
These studies have evaluated factors such as safety, NAD+-related metabolites, physical function, and insulin sensitivity.
However, many of these studies have limited sample sizes and observation periods; therefore, further verification is required regarding long-term efficacy and safety.
Healthy Japanese men – Single oral administration
Healthy elderly men – Sustained oral administration
Postmenopausal women with prediabetes – Sustained oral administration
The studies cited here provide general research information regarding the oral administration of NMN. They do not constitute proof of the efficacy or safety of the "PureStem NMN 300mg" product itself. Furthermore, these findings do not imply that similar results would be achieved through intravenous administration.
We provide information—such as product specifications, raw material quality standards, and handling requirements—tailored to your specific inquiries.